Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CLVLY will - over the next 2 Weeks and hit - by . In that time frame, CLVLY's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
CLVLY shares remained flat 0 in Friday, May 1, 2026's trading session, starting and closing at a previous close of $6.70 to move at $6.70. The stock demonstrated notable intraday movement (see CLVLY's key stats for a full breakdown), fluctuating between $6.31 and $6.70, a +6.18% trading range. While recent weeks have seen some volatility, CLVLY has managed to secure a +2.60% gain over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 6.4K shares changing hands, 5.89K more than the previous session. This amounted to $42.86K in total market activity.
Will CLVLY Continue Its Trend?
According to analyst ratings and projections for CLVLY, Clinuvel Pharmaceuticals Limited shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for CLVLY currently suggest a bearish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the CLVLY stock forecast, now is not the best time to buy CLVLY stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on CLVLY covering social and institutional perspectives.
CLVLY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CLVLY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.04% to 52.62%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 46.67%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 47.54%, maintains a neutral outlook for the long term. Insights into CLVLY's shareholder base show how institutional investors are positioning themselves during these momentum shifts

